Deep Medicine Acquisition (Deep Medicine Acquisition) Pre-Tax Income : $-0.55 Mil (TTM As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Deep Medicine Acquisition Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Deep Medicine Acquisition's pretax income for the three months ended in Sep. 2023 was $-0.27 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2023 was $-0.55 Mil. Deep Medicine Acquisition's pretax margin was %.

Deep Medicine Acquisition Pre-Tax Income Historical Data

The historical data trend for Deep Medicine Acquisition's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deep Medicine Acquisition Pre-Tax Income Chart

Deep Medicine Acquisition Annual Data

Trend

Mar21

Mar22

Mar23

Pre-Tax Income

-0.41

-0.34

Deep Medicine Acquisition Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Pre-Tax Income	Get a 7-Day Free Trial							-0.17	0.65	-0.67	-0.26	-0.27

Competitive Comparison of Deep Medicine Acquisition's Pre-Tax Income

For the Shell Companies subindustry, Deep Medicine Acquisition's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deep Medicine Acquisition's Pre-Tax Income Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Deep Medicine Acquisition's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Deep Medicine Acquisition's Pre-Tax Income falls into.

Deep Medicine Acquisition Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Deep Medicine Acquisition's Pretax Income for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-2.167	+	1.824	+	0	+	0	+	-2.7755575615629E-16
	=	-0.34

Deep Medicine Acquisition's Pretax Income for the quarter that ended in Sep. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-0.361	+	0	+	0	+	0.091	+	0
	=	-0.27

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.55 Mil.

Deep Medicine Acquisition (NAS:DMAQ) Pre-Tax Income Explanation

Deep Medicine Acquisition's Pretax Margin for the quarter that ended in Sep. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-0.27	/	0
	=	%

Deep Medicine Acquisition Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Deep Medicine Acquisition's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Deep Medicine Acquisition (Deep Medicine Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Deep Medicine Acquisition Corp (NAS:DMAQ) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

595 Madison Avenue, 12th Floor, New York, NY, USA, 10017

Website

Deep Medicine Acquisition Corp is a blank check company.

Executives

John Chiang	director	3538 TORRANCE BLVD., UNIT 177, TORRANCE CA 90503
Bryant Fong	director	2170 VALLEJO STREET #101, SAN FRANCISCO CA 94123
Humphrey P Polanen	director, officer: Chief Executive Officer	C/O HERITAGE COMMERCE CORP, 150 ALMADEN BLVD, SAN JOSE CA 95113
Weixuan Luo	officer: Chief Financial Officer	40 WALL STREET, 29TH FLOOR, NEW YORK NY 10005
Marc Hamer	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Bright Vision Sponsor Llc	10 percent owner	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Ronald M. Razmi	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Hongliang Ren	director	7951 S.W. 6TH STREET, SUITE 216, PLANTATION FL 33324
Wanlei Miao	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017
Tina Spires	director	595 MADISON AVENUE, 12TH FLOOR, NEW YORK NY 10017